Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 4.59 CHF 7.75% Market Closed
Market Cap: 185.3m CHF
Have any thoughts about
Molecular Partners AG?
Write Note

Molecular Partners AG
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Molecular Partners AG
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Molecular Partners AG
SIX:MOLN
Revenue
CHf10.4m
CAGR 3-Years
19%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Revenue
$69.6m
CAGR 3-Years
N/A
CAGR 5-Years
129%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Revenue
CHf41m
CAGR 3-Years
252%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Revenue
$202.8m
CAGR 3-Years
-39%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Revenue
CHf149m
CAGR 3-Years
10%
CAGR 5-Years
4%
CAGR 10-Years
14%
Kuros Biosciences AG
SIX:KURN
Revenue
CHf52.5m
CAGR 3-Years
64%
CAGR 5-Years
108%
CAGR 10-Years
N/A
No Stocks Found

Molecular Partners AG
Glance View

Market Cap
185.3m CHF
Industry
Biotechnology

Molecular Partners AG engages in the development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. The company is headquartered in Schlieren, Zuerich and currently employs 163 full-time employees. The company went IPO on 2014-10-22. The firm has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.

MOLN Intrinsic Value
2.91 CHF
Overvaluation 37%
Intrinsic Value
Price

See Also

What is Molecular Partners AG's Revenue?
Revenue
10.4m CHF

Based on the financial report for Jun 30, 2024, Molecular Partners AG's Revenue amounts to 10.4m CHF.

What is Molecular Partners AG's Revenue growth rate?
Revenue CAGR 5Y
-6%

Over the last year, the Revenue growth was -25%. The average annual Revenue growth rates for Molecular Partners AG have been 19% over the past three years , -6% over the past five years .

Back to Top